190 related articles for article (PubMed ID: 29363222)
21. Association of post-transplant donor-specific HLA antibody with liver graft fibrosis during long-term follow-up after pediatric liver transplantation.
Tokodai K; Miyagi S; Nakanishi C; Hara Y; Nakanishi W; Miyazawa K; Shimizu K; Murakami K; Sasano H; Goto M; Unno M; Kamei T
Pediatr Transplant; 2018 May; 22(3):e13169. PubMed ID: 29542229
[TBL] [Abstract][Full Text] [Related]
22. Peri-operative third party red blood cell transfusion in renal transplantation and the risk of antibody-mediated rejection and graft loss.
Fidler S; Swaminathan R; Lim W; Ferrari P; Witt C; Christiansen FT; D'Orsogna LJ; Irish AB
Transpl Immunol; 2013 Dec; 29(1-4):22-7. PubMed ID: 24090807
[TBL] [Abstract][Full Text] [Related]
23. Correlations of lymphocyte subset infiltrates with donor-specific antibodies and acute antibody-mediated rejection in endomyocardial biopsies.
Frank R; Dean SA; Molina MR; Kamoun M; Lal P
Cardiovasc Pathol; 2015; 24(3):168-72. PubMed ID: 25440957
[TBL] [Abstract][Full Text] [Related]
24. C1q Binding Activity of De Novo Donor-specific HLA Antibodies in Renal Transplant Recipients With and Without Antibody-mediated Rejection.
Yell M; Muth BL; Kaufman DB; Djamali A; Ellis TM
Transplantation; 2015 Jun; 99(6):1151-5. PubMed ID: 25839705
[TBL] [Abstract][Full Text] [Related]
25. Proposed Diagnostic Criteria for Chronic Antibody-Mediated Rejection in Liver Allografts.
O'Leary JG; Cai J; Freeman R; Banuelos N; Hart B; Johnson M; Jennings LW; Kaneku H; Terasaki PI; Klintmalm GB; Demetris AJ
Am J Transplant; 2016 Feb; 16(2):603-14. PubMed ID: 26469278
[TBL] [Abstract][Full Text] [Related]
26. Deleterious impact of C3d-binding donor-specific anti-HLA antibodies after pediatric liver transplantation.
Couchonnal E; Rivet C; Ducreux S; Dumortier J; Bosch A; Boillot O; Collardeau-Frachon S; Dubois R; Hervieu V; André P; Scoazec JY; Lachaux A; Dubois V; Guillaud O
Transpl Immunol; 2017 Dec; 45():8-14. PubMed ID: 28782692
[TBL] [Abstract][Full Text] [Related]
27. Graft Immunocomplex Capture Fluorescence Analysis to Detect Donor-Specific Antibodies and HLA Antigen Complexes in the Allograft.
Nakamura T; Ushigome H; Watabe K; Imanishi Y; Masuda K; Matsuyama T; Harada S; Koshino K; Iida T; Nobori S; Yoshimura N
Immunol Invest; 2017 Apr; 46(3):295-304. PubMed ID: 28151033
[TBL] [Abstract][Full Text] [Related]
28. Increased macrophage density of cardiac allograft biopsies is associated with antibody-mediated rejection and alloantibodies to HLA antigens.
Xu L; Collins J; Drachenberg C; Kukuruga D; Burke A
Clin Transplant; 2014 May; 28(5):554-60. PubMed ID: 24580037
[TBL] [Abstract][Full Text] [Related]
29. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.
Ali S; Ormsby A; Shah V; Segovia MC; Kantz KL; Skorupski S; Eisenbrey AB; Mahan M; Huang MA
Transpl Immunol; 2012 Jan; 26(1):62-9. PubMed ID: 21907804
[TBL] [Abstract][Full Text] [Related]
30. Combination of Total Lymphoid Irradiation, Low-Dose IVIG and ATG as Rescue Therapy for Highly Sensitized and Antibody-Mediated Rejection Renal Transplant Recipients.
Zhu D; Qi G; Tang Q; Li L; Yang C; Lin M; Wu B; Xu M; Cai J; Zhu T; Rong R
Clin Transpl; 2014; ():215-21. PubMed ID: 26281148
[TBL] [Abstract][Full Text] [Related]
31. Identification of liver transplant biopsy phenotypes associated with distinct liver biological markers and allograft survival.
Demir Z; Raynaud M; Aubert O; Debray D; Sebagh M; Duong Van Huyen JP; Del Bello A; Jolivet NC; Paradis V; Durand F; Muratot S; Lozach C; Chardot C; Francoz C; Kamar N; Sarnacki S; Coilly A; Samuel D; Vibert E; Féray C; Lefaucheur C; Loupy A
Am J Transplant; 2024 Jun; 24(6):954-966. PubMed ID: 38097016
[TBL] [Abstract][Full Text] [Related]
32. Pregnancy and donor-specific HLA-antibody-mediated rejection after liver transplantation: "Liaisons dangereuses"?
Dumortier J; Dedic T; Erard-Poinsot D; Rivet C; Guillaud O; Chambon-Augoyard C; Bosch A; Lachaux A; Couchonnal E; Thaunat O; Boillot O; Dubois V
Transpl Immunol; 2019 Jun; 54():47-51. PubMed ID: 30743001
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic Contribution of Donor-Specific Antibody Characteristics to Uncover Late Silent Antibody-Mediated Rejection-Results of a Cross-Sectional Screening Study.
Eskandary F; Bond G; Kozakowski N; Regele H; Marinova L; Wahrmann M; Kikić Ž; Haslacher H; Rasoul-Rockenschaub S; Kaltenecker CC; König F; Hidalgo LG; Oberbauer R; Halloran PF; Böhmig GA
Transplantation; 2017 Mar; 101(3):631-641. PubMed ID: 27120452
[TBL] [Abstract][Full Text] [Related]
34. Chronic AMR in Liver Transplant: Validation of the 1-Year cAMR Score's Ability to Determine Long-term Outcome.
O'Leary JG; Smith C; Cai J; Hart B; Jennings LW; Everly M; Klintmalm GB; Demetris AJ
Transplantation; 2017 Sep; 101(9):2062-2070. PubMed ID: 28452922
[TBL] [Abstract][Full Text] [Related]
35. Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation.
Wozniak LJ; Hickey MJ; Venick RS; Vargas JH; Farmer DG; Busuttil RW; McDiarmid SV; Reed EF
Transplantation; 2015 Jul; 99(7):1416-22. PubMed ID: 26038872
[TBL] [Abstract][Full Text] [Related]
36. Targeted monitoring of donor-specific HLA antibodies following renal transplantation.
Almeshari K; Pall A; Chaballout A; Elgamal H; Almana H; Alzayer F; Abaalkhail N; Altalhi M
Clin Transpl; 2011; ():395-400. PubMed ID: 22755437
[TBL] [Abstract][Full Text] [Related]
37. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?
Crespo M; Torio A; Mas V; Redondo D; Pérez-Sáez MJ; Mir M; Faura A; Guerra R; Montes-Ares O; Checa MD; Pascual J
Transpl Immunol; 2013 Dec; 29(1-4):28-33. PubMed ID: 23907088
[TBL] [Abstract][Full Text] [Related]
38. Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation.
Malheiro J; Tafulo S; Dias L; Martins LS; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
Transpl Immunol; 2015 Mar; 32(2):66-71. PubMed ID: 25661873
[TBL] [Abstract][Full Text] [Related]
39. Significance of low-level DSA detected by solid-phase assay in association with acute and chronic antibody-mediated rejection.
Hirai T; Kohei N; Omoto K; Ishida H; Tanabe K
Transpl Int; 2012 Sep; 25(9):925-34. PubMed ID: 22764746
[TBL] [Abstract][Full Text] [Related]
40. De Novo Anti-HLA DSA Characteristics and Subclinical Antibody-Mediated Kidney Allograft Injury.
Yamamoto T; Watarai Y; Takeda A; Tsujita M; Hiramitsu T; Goto N; Narumi S; Katayama A; Morozumi K; Uchida K; Kobayashi T
Transplantation; 2016 Oct; 100(10):2194-202. PubMed ID: 26636737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
